CN103402982B - 2-氨甲酰环氨基脲衍生物的合成 - Google Patents

2-氨甲酰环氨基脲衍生物的合成 Download PDF

Info

Publication number
CN103402982B
CN103402982B CN201280011348.XA CN201280011348A CN103402982B CN 103402982 B CN103402982 B CN 103402982B CN 201280011348 A CN201280011348 A CN 201280011348A CN 103402982 B CN103402982 B CN 103402982B
Authority
CN
China
Prior art keywords
formula
compound
solvent
alkyl
solvents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280011348.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103402982A (zh
Inventor
B·埃尔巴
I·S·高鲁
F·K·克莱因贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103402982(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to CN201610412757.0A priority Critical patent/CN106083840B/zh
Publication of CN103402982A publication Critical patent/CN103402982A/zh
Application granted granted Critical
Publication of CN103402982B publication Critical patent/CN103402982B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201280011348.XA 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成 Active CN103402982B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610412757.0A CN106083840B (zh) 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
US61/448,774 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610412757.0A Division CN106083840B (zh) 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成

Publications (2)

Publication Number Publication Date
CN103402982A CN103402982A (zh) 2013-11-20
CN103402982B true CN103402982B (zh) 2016-07-13

Family

ID=45787206

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201280011348.XA Active CN103402982B (zh) 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成
CN201610412757.0A Active CN106083840B (zh) 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201610412757.0A Active CN106083840B (zh) 2011-03-03 2012-03-01 2-氨甲酰环氨基脲衍生物的合成

Country Status (33)

Country Link
US (3) US9650373B2 (https=)
EP (1) EP2681192B1 (https=)
JP (1) JP6022485B2 (https=)
KR (1) KR101851421B1 (https=)
CN (2) CN103402982B (https=)
AR (2) AR088714A1 (https=)
AU (1) AU2012222346B2 (https=)
BR (1) BR112013021882A2 (https=)
CA (1) CA2828509C (https=)
CL (1) CL2013002521A1 (https=)
CO (1) CO6751286A2 (https=)
DK (1) DK2681192T3 (https=)
EA (4) EA025381B1 (https=)
EC (1) ECSP13012914A (https=)
ES (1) ES2663717T3 (https=)
GT (1) GT201300211A (https=)
HU (1) HUE036319T2 (https=)
IL (1) IL228023A (https=)
MA (1) MA34982B1 (https=)
MX (2) MX351740B (https=)
MY (1) MY163214A (https=)
NO (1) NO2681192T3 (https=)
PE (1) PE20140917A1 (https=)
PH (1) PH12013501796A1 (https=)
PL (1) PL2681192T3 (https=)
PT (1) PT2681192T (https=)
SG (1) SG192793A1 (https=)
SI (1) SI2681192T1 (https=)
TN (1) TN2013000354A1 (https=)
TW (2) TWI597279B (https=)
UA (1) UA112539C2 (https=)
WO (1) WO2012117071A1 (https=)
ZA (1) ZA201306174B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1816549A (zh) * 2003-05-02 2006-08-09 诺瓦提斯公司 磷脂酰肌醇3-激酶抑制剂
WO2007087427A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2010029082A1 (en) * 2008-09-10 2010-03-18 Novartis Ag Organic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
DE60023926T2 (de) 1999-09-10 2006-07-20 Merck & Co., Inc. Tyrosin kinase inhibitoren
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2240475B1 (en) * 2007-12-20 2013-09-25 Novartis AG Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1816549A (zh) * 2003-05-02 2006-08-09 诺瓦提斯公司 磷脂酰肌醇3-激酶抑制剂
WO2007087427A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2010029082A1 (en) * 2008-09-10 2010-03-18 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
PH12013501796A1 (en) 2022-10-26
CA2828509C (en) 2018-11-20
DK2681192T3 (en) 2018-04-16
KR20140009432A (ko) 2014-01-22
JP6022485B2 (ja) 2016-11-09
EA032802B1 (ru) 2019-07-31
NO2681192T3 (https=) 2018-05-26
IL228023A (en) 2017-04-30
TW201247660A (en) 2012-12-01
TWI597279B (zh) 2017-09-01
CA2828509A1 (en) 2012-09-07
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
EA201691331A1 (ru) 2017-01-30
BR112013021882A2 (pt) 2016-07-19
EP2681192B1 (en) 2017-12-27
US20170240509A1 (en) 2017-08-24
EP2681192A1 (en) 2014-01-08
MX2013010132A (es) 2013-10-30
ZA201306174B (en) 2014-05-28
ES2663717T3 (es) 2018-04-16
CN106083840B (zh) 2020-01-03
AR123584A2 (es) 2022-12-21
PT2681192T (pt) 2018-04-02
NZ614173A (en) 2015-04-24
US20170355677A1 (en) 2017-12-14
MA34982B1 (fr) 2014-03-01
EA201892052A1 (ru) 2019-02-28
SI2681192T1 (en) 2018-04-30
UA112539C2 (uk) 2016-09-26
US20130331579A1 (en) 2013-12-12
MX351740B (es) 2017-10-26
CN103402982A (zh) 2013-11-20
AU2012222346B2 (en) 2015-05-07
ECSP13012914A (es) 2013-11-29
SG192793A1 (en) 2013-09-30
US9650373B2 (en) 2017-05-16
PE20140917A1 (es) 2014-08-14
GT201300211A (es) 2014-12-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
TW201722916A (zh) 2017-07-01
US10059670B2 (en) 2018-08-28
AR088714A1 (es) 2014-07-02
TN2013000354A1 (en) 2015-01-20
EA201391267A1 (ru) 2014-01-30
WO2012117071A1 (en) 2012-09-07
CL2013002521A1 (es) 2014-02-14
EA201792068A2 (ru) 2018-01-31
TWI607994B (zh) 2017-12-11
CN106083840A (zh) 2016-11-09
CO6751286A2 (es) 2013-09-16
EA025381B1 (ru) 2016-12-30
IL228023A0 (en) 2013-09-30
EA201792068A3 (ru) 2018-05-31
KR101851421B1 (ko) 2018-04-23
HUE036319T2 (hu) 2018-06-28
JP2014511387A (ja) 2014-05-15
US9776966B2 (en) 2017-10-03

Similar Documents

Publication Publication Date Title
CN103402982B (zh) 2-氨甲酰环氨基脲衍生物的合成
CN101160317B (zh) 制备大环化合物的方法
CN116964058A (zh) Kras g12d抑制剂及其在医药上的应用
FR2867778A1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
ZA200504893B (en) Viral polymerase inhibitors
PT751944E (pt) Tiazolidinas e oxazolidinas substituidas por um anel piridina e sua utilizacao como agentes hipoglicemicos
Knölker et al. Cycloadditions of Allylsilanes, Part 11. Stereoselective Synthesis of Hydroxycyclopentanes and Hydroxymethylcyclobutanes by Titanium Tetrachloride-Promoted [3+ 2] and [2+ 2] Cycloadditions of Sterically Hindered Allylsilanes and Subsequent Oxidative Cleavage of the Carbon-Silicon Bond
WO2022107755A1 (ja) 新規アクリジニウム塩およびその製造方法
KR19990013367A (ko) 피라졸리논 화합물의 제조 방법
TW200811089A (en) One-pot condensation-reduction methods for preparing substituted allylic alcohols
KR20010091379A (ko) 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
JPH0667942B2 (ja) テトラヒドロ3環式化合物
KR20090100759A (ko) 모사프리드 제조용 중간체의 제조방법
MX2007016093A (es) Proceso para la produccion de sulfonatos de (alcoxicarbonilamino)- alquilo.
WO2009081843A1 (ja) 1,1,3,4-ブタンテトラカルボン酸エステルの製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant